| Symbol | OVATF |
|---|---|
| Name | OVATION SCIENCE INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6E 3Z3 Canada BC 1003-1166 Alberni Street |
| Telephone | +1 604 982-5700 |
| Fax | — |
| — | |
| Website | https://www.ovationscience.com |
| Incorporation | CA |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Dale Matheson Carr-Hilton Labonte LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | 0001751058 |
| Description | Ovation Science, using its propriatory drug delivery system called INVISICARE, focuses on licensing its topical and transdermal cannabis products to licensed state operators as well as providing private label CBD products to international marketers.Ovation Science is an innovative drug development company with a high performance patented topical and transdermal INVISICARE delivery system; which enhances the delivery of ingredients to and through the skin. Ovation has its own two product lines and licensees along with an international supply agreement. All product are powered by Ovations proprietary Invisicare technology. Additional info from OTC: |
No news found.